Out in open

The more, the merrier. Join and conjoin!

Thursday, June 28, 2007

Health Issues Associated with Celebrex

Health Issues Associated with the Use of Celebrex

            In 2002, the FDA issued a health warning about Celebrex.  This was after the drug had been linked to an increase in the likelihood of its users developing cardiovascular disease.  In 2004, the National Institutes of Health announced that it had suspended the use of Celebrex for all participants, in its colorectal cancer prevention clinical trial (which was conducted by the National Cancer Institute).  Despite the growing controversy surrounding the use of the drug (and after Pfizer pulled it's cousin COX-2 inhibitor dr! ug Bextra from the market altogether); in 2006, The U.S. Food and Drug Administration approved Celebrex, for the relief of signs and symptoms related to Juvenile Rheumatoid Arthritis; in patients two years of age and older.